Ivd Reagent Stripe Machine Manufacturer – COVID-19 Detection reagent equipment – CILIANG
Ivd Reagent Stripe Machine Manufacturer – COVID-19 Detection reagent equipment – CILIANG Detail:
Neutralizing antibody against SARS-CoV-2 can resist human immune SARS-CoV-2 infection.
Therefore, the detection of neutralizing antibodies against SARS-CoV-2 has important clinical significance for patients with convalescent infection or for vaccination of SARS-CoV-2 vaccine.
The SARS-CoV-2 Neutralizing Antibody Test Kit is for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in human serum, plasma or whole blood sample. The test kit is intended for use outside the body only (in vitro diagnostic use) for professional use and should not be used to diagnose acute SARS-CoV-2 infection.
Analyzer
Test Kit
Product
Method
Specimen type
Specimen volume
Test time
Package size
Storage
SARS-CoV-2 Neutralizing Antibody Test Kit
Fluorescence Immunochromatography
Serum, plasma or whole blood sample
25µl
10 minutes
25 pcs/box; 50 pcs/box
4℃~30℃
Product detail pictures:
Related Product Guide:
The really abundant projects management experiences and 1 to just one provider model make the high importance of business enterprise communication and our easy understanding of your expectations for Ivd Reagent Stripe Machine Manufacturer – COVID-19 Detection reagent equipment – CILIANG, The product will supply to all over the world, such as: Honduras, Sudan, France, We have exported our products all over the world, especially the USA and European countries. Furthermore, all of our products are manufactured with advanced equipment and strict QC procedures to ensure high quality.If you are interested in any of our products, please don't hesitate to contact us. We will try our best to meet your needs.
By Isabel from Lisbon - 2018.12.30 10:21
Hope that the company could stick to the enterprise spirit of "Quality, Efficiency, Innovation and Integrity", it will be better and better in the future.
By Victor Yanushkevich from New Orleans - 2018.06.18 17:25
